Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Can immunotherapy stop colorectal Cancer's return?

NCT ID NCT07058012

First seen May 20, 2026 · Last updated Jun 13, 2026 · Updated 3 times

Summary

This study tests if immunotherapy drugs (cemiplimab, fianlimab, and REGN7075) can clear leftover cancer DNA in the blood of colorectal cancer patients after surgery and chemotherapy. The goal is to delay or prevent the cancer from coming back. About 79 adults with stage II/III colorectal cancer who still have cancer DNA in their blood will participate.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for COLO-RECTAL CANCER are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Allegheny General Hospital

    RECRUITING

    Pittsburgh, Pennsylvania, 15212, United States

  • Ballad Health Cancer Center - Kingsport

    RECRUITING

    Kingsport, Tennessee, 37660, United States

  • Bon Secours St. Francis Medical Center

    RECRUITING

    Midlothian, Virginia, 23114, United States

  • First Health of the Carolinas

    RECRUITING

    Pinehurst, North Carolina, 28374, United States

  • Missouri Baptist

    RECRUITING

    St Louis, Missouri, 63131, United States

  • University of Florida

    RECRUITING

    Gainesville, Florida, 32611, United States

  • University of Iowa - Holden Comprehensive Cancer Center

    RECRUITING

    Iowa City, Iowa, 52242, United States

  • University of Kansas Cancer Center

    RECRUITING

    Kansas City, Kansas, 66160, United States

  • Virginia Commonwealth University - Massey

    RECRUITING

    Richmond, Virginia, 23298, United States

Conditions

The condition(s) this trial relates to.

colonic neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.